STI-7349 - The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Keytruda (pembrolizumab) - Merck (MSD)
Tevimbra (tislelizumab-jsgr) - BeOne Medicines
http://clinicaltrials.gov/ct2/show/NCT05978102
 
Jul 25, 2025
 
Next